- Home
- CNTX vs DMF Comparison
CNTX vs DMF Comparison
Compare CNTX & DMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- DMF
- Stock Information
- Founded
- CNTX 2015
- DMF 1988
- Country
- CNTX United States
- DMF United States
- Employees
- CNTX N/A
- DMF N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- DMF Finance/Investors Services
- Sector
- CNTX Health Care
- DMF Finance
- Exchange
- CNTX Nasdaq
- DMF Nasdaq
- Market Cap
- CNTX 149.6M
- DMF 149.3M
- IPO Year
- CNTX 2021
- DMF N/A
- Fundamental
- Price
- CNTX $1.30
- DMF $7.24
- Analyst Decision
- CNTX Strong Buy
- DMF
- Analyst Count
- CNTX 3
- DMF 0
- Target Price
- CNTX $6.83
- DMF N/A
- AVG Volume (30 Days)
- CNTX 210.1K
- DMF 60.7K
- Earning Date
- CNTX 11-06-2024
- DMF 01-01-0001
- Dividend Yield
- CNTX N/A
- DMF 2.66%
- EPS Growth
- CNTX N/A
- DMF N/A
- EPS
- CNTX N/A
- DMF 0.15
- Revenue
- CNTX N/A
- DMF N/A
- Revenue This Year
- CNTX N/A
- DMF N/A
- Revenue Next Year
- CNTX N/A
- DMF N/A
- P/E Ratio
- CNTX N/A
- DMF $45.13
- Revenue Growth
- CNTX N/A
- DMF N/A
- 52 Week Low
- CNTX $0.77
- DMF $5.37
- 52 Week High
- CNTX $2.75
- DMF $6.79
- Technical
- Relative Strength Index (RSI)
- CNTX 25.94
- DMF 50.76
- Support Level
- CNTX $1.56
- DMF $7.17
- Resistance Level
- CNTX $2.32
- DMF $7.27
- Average True Range (ATR)
- CNTX 0.16
- DMF 0.08
- MACD
- CNTX -0.07
- DMF 0.01
- Stochastic Oscillator
- CNTX 17.88
- DMF 72.46
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About DMF BNY Mellon Municipal Income Inc.
BNY Mellon Municipal Income, Inc. is a non-diversified closed-end management investment company. Its investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The fund invests in municipal obligations that are rated investment grade and have maturities of less than one year. The company targets to invest in the sector such as education, pre-refunded muni, utility, transportation, healthcare, special tax, state/territory general obligations, industry revenue, and pollution control.